MLchartDataset catalogue

Botanical extract DCB-BO1301

Term · Oncology and biomedicine · MLC-T-ONC-012077

A proprietary botanical, galactolipid-enriched extract derived from the edible plant Crassocephalum crepidioides (Zhaohe Cao), with potential anti-inflammatory and antineoplastic activities. Upon oral administration, DCB-BO1301 may inhibit the growth of certain types of tumor cells, although the exact mechanism of action has yet to be fully elucidated.

Table 1. Record
IdentifierMLC-T-ONC-012077
FieldOncology and biomedicine
SynonymsZhaohe Cao-based botanical drug DCB-BO1301
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012077",
  "term": "Botanical extract DCB-BO1301",
  "field": "Oncology and biomedicine",
  "definition": "A proprietary botanical, galactolipid-enriched extract derived from the edible plant Crassocephalum crepidioides (Zhaohe Cao), with potential anti-inflammatory and antineoplastic activities. Upon oral administration, DCB-BO1301 may inhibit the growth of certain types of tumor cells, although the exact mechanism of action has yet to be fully elucidated.",
  "synonyms": [
    "Zhaohe Cao-based botanical drug DCB-BO1301"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/botanical-extract-dcb-bo1301/"
}

Record 3,755 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.